You are here

Vytorin

Kaiser Sues Merck, Generic Drug Firm Over Millions in Losses Due to Alleged "Pay-for-Delay" Scheme

BioSpace

Thu, 07/29/21 - 11:08 pm

Kaiser Permanente

Merck to spin off new $6.5 billion firm focused on women’s health, older drugs

Stat

Wed, 02/5/20 - 10:34 am

Merck's Vytorin set for massive sales slide as generics hit

Fierce Pharma

Sun, 04/30/17 - 12:53 pm

Teva Pharmaceutical

FDA approves Impax generic of Merck's cholesterol drug Vytorin

Yahoo/Reuters

Wed, 04/26/17 - 09:36 pm

The Top 5 Drug Patents Expiring in 2017

Investopedia

Mon, 01/16/17 - 11:48 am

Bristol-Myers Squibb

Sandostatin LAR

Merck’s Zetia and Vytorin: More Generic Competition in 2017

Market Realist

Thu, 12/29/16 - 12:28 pm

Merck says U.S. FDA rejects its claim that Zetia and Vytorin cut heart risk

Yahoo/Reuters

Tue, 02/16/16 - 10:04 am

Merck's Vytorin Study Epitomizes Inherent Risks Of Major Clinical Trials

Forbes

Wed, 12/16/15 - 11:26 am

clinical trials

Merck fails to win FDA panel backing for Vytorin heart claim

Yahoo/Reuters

Mon, 12/14/15 - 10:19 pm

advisory panels

Merck's 'landmark' Zetia data hits NEJM, giving a boost to all LDL-fighting meds

Fierce Biotech

Thu, 06/4/15 - 09:18 am

New England Journal of Medicine

How Marketing And Media Muddled The Truth About The Heart Drug Vytorin

Forbes

Fri, 04/17/15 - 12:35 pm

Schering Plough

Can study data spur Merck CV sales?

Medical Marketing and Media

Mon, 01/5/15 - 09:36 am

New data fuels doctors' demands to rewrite U.S. heart guidelines

Reuters

Fri, 11/21/14 - 11:05 am

LDL cholesterol

Long-Awaited Study Boosts Merck, Could Be Good News for Regeneron, Amgen

Barron's

Mon, 11/17/14 - 04:03 pm

After Years Under Attack, Merck's Vytorin Proves Effective

Forbes

Mon, 11/17/14 - 09:03 am

A Day Of Reckoning Approaches For Merck And Its Critics

Forbes

Thu, 11/13/14 - 10:29 am

Does a Positive Result for the Vytorin Trial Really Help Merck?

WSJ Pharmalot

Tue, 11/11/14 - 10:33 am

clinical trial data

Merck expects no writedowns for Zetia, Vytorin cholesterol drugs

Yahoo/Reuters

Mon, 11/10/14 - 03:53 pm

Cholesterol Drug Heart Study Continues, But Will Merck's Vytorin Really IMPROVE-IT?

Forbes

Mon, 03/18/13 - 10:45 am

Merck Says A Crucial Vytorin Study Will Continue

Pharmalot

Tue, 03/12/13 - 11:38 am

Pages